ClinicalTrials.Veeva

Menu

The Efficacy of Transcutaneous Pulsed Radiofrequency Acupuncture for Knee Osteoarthritis

S

Shin Kong Wu Ho-Su Memorial Hospital

Status

Enrolling

Conditions

Osteoarthritis (OA) of the Knee

Treatments

Device: transcutaneous pulsed radiofrequency acupuncture
Device: Sham Comparison

Study type

Interventional

Funder types

Other

Identifiers

NCT06702046
20240723R

Details and patient eligibility

About

Efficacy of transcutaneous acupoint pulsed radiofrequency with rehabilitation for knee osteoarthritis.

Full description

With the aging population, knee osteoarthritis (KOA) has become a major issue affecting functional living and causing socioeconomic burdens. Its etiology includes biomechanical abnormalities, genetics, hormones, and environmental factors. KOA causes pain, stiffness, and muscle weakness, affecting daily activities and quality of life. Previous studies have shown that traditional acupuncture or electroacupuncture can improve pain and function in knee osteoarthritis. In recent years, pulsed radiofrequency therapy has gradually been applied for pain control in KOA. However, both treatments are invasive, and patients may fear and avoid needle insertion, which also has a higher risk of complications. This study aims to combine the strengths of both treatments by using transcutaneous pulsed radiofrequency(TCPRF) at acupuncture points. This non-invasive treatment approach aims to achieve effective pain control, allowing patients to participate more actively in rehabilitation therapy.

Enrollment

90 estimated patients

Sex

All

Ages

45 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age from 45 to 85 year-old with knee pain for more than six months
  • Fulfill the combined clinical and radiographic criteria of knee OA established by the American College of Rheumatology with a Kellgren and Lawrence score of 2 or greater
  • Pain score above 3 (range 0-10 on the visual analog scale; higher scores indicate greater pain
  • Could participate in 4 weeks of treatment and 3 months of follow-up

Exclusion criteria

  • Knee OA combined with any infection, inflammation, autoimmune disease, or fracture
  • History or underlying disease that would affect posture and balance, such as malignancy, dizziness, vertigo, or stroke
  • Ever underwent any type of knee operation or internal fixation
  • Pregnant or planning to become pregnant
  • Receiving other treatment for knee OA in previous 3 months
  • History of epilepsy, electronic devices implanted in the body
  • Active infection at the stimulator contact site
  • Lack of informed consent
  • Any other reason thought likely to result in inability to complete the trial

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

90 participants in 2 patient groups

TCPRF acupuncture group
Experimental group
Description:
The investigators choose ST34 (Liangqiu), SP10 (Xuehai), GB34 (Yanglingquan), SP9 (Yinlingquan) around the affected knee. The TCPRF device is a wearable modality with innovative pulse radiofrequency technology aimed at alleviating symptomatic chronic pain, which revealed that UHF (500-kHz sine wave, 2-Hz frequency with a 25-ms pulse). It was attached to the electrode pad through magnetic attraction. A 500-KHz stimulus was delivered. The symmetric two-phase sine wave has a 2-Hz frequency witha 25-ms pulse width. The treatment has 15 min per time. treatment is administered for 30 minutes each session, divided into two 15-minute phases. After the first 15 minutes, the treatment is paused and then restarted for an additional 15 minutes. The output peak current was 13.2 mA and the output peak voltage was 6.6 V at 500 Ω.
Treatment:
Device: transcutaneous pulsed radiofrequency acupuncture
Sham group
Sham Comparator group
Description:
same protocol will be done on the same acupoints, but the machine will be turn off interiorly. Therefore, although the machine still has lights and a vibrating sensation, it will not release PRF waves.
Treatment:
Device: Sham Comparison

Trial contacts and locations

1

Loading...

Central trial contact

Yu-Ting Lin, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems